35812601|t|Effective Use of Ketamine-Dexmedetomidine Following Propofol-Induced Hyperlactatemia: A Case Report.
35812601|a|There are limited options for intravenous anesthetics and a lack of available information on the use of ketamine infusion during intracranial surgeries. We present a patient case report of hyperlactatemia during a craniotomy with neuromonitoring while on a propofol infusion with arterial lactate rising from 2.1 mmol/L to a peak of 5.0 mmol/L before reducing to 3.9 mmol/L after the transition to a mixed ketamine and dexmedetomidine infusion in order to maintain neuromonitoring quality and an appropriate depth of anesthesia. No complications were caused by the use of ketamine during this extended neurosurgery case.
35812601	17	25	Ketamine	Chemical	MESH:D007649
35812601	26	41	Dexmedetomidine	Chemical	MESH:D020927
35812601	52	60	Propofol	Chemical	MESH:D015742
35812601	69	84	Hyperlactatemia	Disease	MESH:D065906
35812601	205	213	ketamine	Chemical	MESH:D007649
35812601	267	274	patient	Species	9606
35812601	290	305	hyperlactatemia	Disease	MESH:D065906
35812601	358	366	propofol	Chemical	MESH:D015742
35812601	390	397	lactate	Chemical	MESH:D019344
35812601	507	515	ketamine	Chemical	MESH:D007649
35812601	520	535	dexmedetomidine	Chemical	MESH:D020927
35812601	673	681	ketamine	Chemical	MESH:D007649
35812601	Cotreatment	MESH:D007649	MESH:D015742
35812601	Positive_Correlation	MESH:D015742	MESH:D019344
35812601	Negative_Correlation	MESH:D020927	MESH:D065906
35812601	Positive_Correlation	MESH:D015742	MESH:D065906
35812601	Negative_Correlation	MESH:D007649	MESH:D065906
35812601	Cotreatment	MESH:D007649	MESH:D020927
35812601	Cotreatment	MESH:D015742	MESH:D020927

